# SOBR Safe, Inc.: overview SOBR · OTC · CIK 1425627 · [Communication](/sectors/communication.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/sobr.md) · [Financials](/companies/sobr/financials.md) · [Filings](/companies/sobr/filings.md) · [Insiders](/companies/sobr/insiders.md) Latest reported revenue: [$29.1k](/filings/0001477932-26-005085.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 14, 2026 (XBRL us-gaap:Revenues, accession 0001477932-26-005085). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [46.1](/filings/0001477932-25-008092.md) | [64.4 d](/filings/0001477932-26-002117.md) | [86.6](/filings/0001477932-26-002680.md) | [104](/filings/0001477932-26-005085.md) | [109](/filings/0001477932-25-008092.md) | [138 d](/filings/0001477932-26-002117.md) | [79.0](/filings/0001477932-26-002680.md) | [29.1](/filings/0001477932-26-005085.md) | | Gross margin | % | [65.3%](/filings/0001477932-25-008092.md) | [(73.3%) d](/filings/0001477932-26-002117.md) | [58.8%](/filings/0001477932-26-002680.md) | [57.5%](/filings/0001477932-26-005085.md) | [34.8%](/filings/0001477932-25-008092.md) | [63.0% d](/filings/0001477932-26-002117.md) | [56.9%](/filings/0001477932-26-002680.md) | [(403.5%)](/filings/0001477932-26-005085.md) | | Operating margin | % | [(4005.9%)](/filings/0001477932-25-008092.md) | [(3479.9%) d](/filings/0001477932-26-002117.md) | [(2254.9%)](/filings/0001477932-26-002680.md) | [(1985.1%)](/filings/0001477932-26-005085.md) | [(2043.4%)](/filings/0001477932-25-008092.md) | [(2114.1%) d](/filings/0001477932-26-002117.md) | [(2923.9%)](/filings/0001477932-26-002680.md) | [(10547.2%)](/filings/0001477932-26-005085.md) | | Net margin | % | [(3991.4%)](/filings/0001477932-25-008092.md) | [(3390.9%) d](/filings/0001477932-26-002117.md) | [(2169.4%)](/filings/0001477932-26-002680.md) | [(1914.5%)](/filings/0001477932-26-005085.md) | [(2008.0%)](/filings/0001477932-25-008092.md) | [(2099.0%) d](/filings/0001477932-26-002117.md) | [(2902.3%)](/filings/0001477932-26-002680.md) | [(10530.3%)](/filings/0001477932-26-005085.md) | | Diluted EPS | $ per share | [(58.26)](/filings/0001477932-25-008092.md) | not reported | [(1.46)](/filings/0001477932-26-002680.md) | [(1.32)](/filings/0001477932-26-005085.md) | [(1.44)](/filings/0001477932-25-008092.md) | not reported | [(0.92)](/filings/0001477932-26-002680.md) | [(1.08)](/filings/0001477932-26-005085.md) | | Free cash flow | $k | not reported | [(1,611) d](/filings/0001477932-26-002117.md) | not reported | not reported | not reported | [(1,627) d](/filings/0001477932-26-002117.md) | not reported | not reported | - Revenue. XBRL Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | [0.0](/filings/0001477932-23-002085.md) | [35.3](/filings/0001477932-24-001629.md) | [157](/filings/0001477932-25-002746.md) | [213](/filings/0001477932-26-002117.md) | [437](/filings/0001477932-26-002117.md) | | Gross margin | % | not reported | [45.3%](/filings/0001477932-24-001629.md) | [39.6%](/filings/0001477932-25-002746.md) | [9.0%](/filings/0001477932-26-002117.md) | [53.8%](/filings/0001477932-26-002117.md) | | Operating margin | % | not reported | [(29481.5%)](/filings/0001477932-24-001629.md) | [(6103.6%)](/filings/0001477932-25-002746.md) | [(3608.1%)](/filings/0001477932-26-002117.md) | [(2093.7%)](/filings/0001477932-26-002117.md) | | Net margin | % | not reported | [(34978.0%)](/filings/0001477932-24-001629.md) | [(6494.1%)](/filings/0001477932-25-002746.md) | [(4046.9%)](/filings/0001477932-26-002117.md) | [(2046.3%)](/filings/0001477932-26-002117.md) | | Diluted EPS | $ per share | [(0.30)](/filings/0001477932-22-001338.md) | not reported | [(619.15)](/filings/0001477932-25-002746.md) | [172.19](/filings/0001477932-26-002117.md) | [6.12](/filings/0001477932-26-002117.md) | | Free cash flow | $k | not reported | not reported | not reported | [(6,522)](/filings/0001477932-26-002117.md) | [(6,996)](/filings/0001477932-26-002117.md) | - Revenue. XBRL Revenue: us-gaap:Revenues. - Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues. - Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareBasicAndDiluted; Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sobr/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [JANE STREET GROUP, LLC](/funds/1595888.md) | 2026-06-30 | $36.0k | 48,853 | | New +48,853 | | [CITADEL ADVISORS LLC](/funds/1423053.md) | 2026-06-30 | $23.9k | 32,508 | | New +32,508 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $12.3k | 16,745 | | Reduced −33,705 | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $7.6k | 10,363 | | Unchanged | | [Scientech Research LLC](/funds/2011556.md) | 2026-06-30 | $7.5k | 10,243 | | New +10,243 | | [Tower Research Capital LLC (TRC)](/funds/1533421.md) | 2026-06-30 | $2.2k | 3,004 | | Reduced −3,064 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $2.1k | 2,914 | | Reduced −911 | | [OSAIC HOLDINGS, INC.](/funds/1677044.md) | 2026-06-30 | $1.1k | 1,500 | | New +1,500 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $737 | 1,001 | | Unchanged | | [ST GERMAIN D J CO INC](/funds/831571.md) | 2026-06-30 | $736 | 1,000 | | Unchanged | ## Recent filings [All 412 filings](/companies/sobr/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-16 | 16:54 ET | [S-1/A](/filings/0001477932-26-006309.md) | Registration statement, amended | 0001477932-26-006309 | | 2026-10-02 | 17:14 ET | [8-K](/filings/0001477932-26-006034.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-006034 | | 2026-09-25 | 16:30 ET | [8-K](/filings/0001477932-26-005798.md) | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001477932-26-005798 | | 2026-09-23 | 12:38 ET | [8-K](/filings/0001477932-26-005759.md) | 8.01 Other events | 0001477932-26-005759 | | 2026-09-18 | 16:10 ET | [8-K](/filings/0001477932-26-005700.md) | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001477932-26-005700 | | 2026-09-15 | 15:50 ET | [8-K](/filings/0001477932-26-005610.md) | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001477932-26-005610 | | 2026-09-09 | 17:18 ET | [S-1](/filings/0001477932-26-005494.md) | Registration statement | 0001477932-26-005494 | | 2026-08-27 | 17:00 ET | [8-K](/filings/0001477932-26-005300.md) | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001477932-26-005300 | | 2026-08-14 | 16:31 ET | [10-Q](/filings/0001477932-26-005085.md) | Quarterly report, period 2026-06-30 | 0001477932-26-005085 | | 2026-07-17 | 17:29 ET | [8-K](/filings/0001477932-26-004383.md) | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001477932-26-004383 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001477932-26-002117.md), filed Apr 10, 2026. ## Forecast league Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/779b0d74-98ff-4895-8d5b-95b2b40ce850) ## About the filer - CIK: 1425627 - Tickers: SOBR - Exchange: OTC - SIC code: 2721 Periodicals: Publishing or Publishing & Printing - State of incorporation: DE - Filer category: Non-accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 29, 2026, 14:59 ET. No prices; not investment advice.